3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
11
Radiotherapy
10
Cisplatin
4
Carmustine
4
Vincristine
3
Surgical Procedures, Operative
3
Methotrexate
3
Lomustine
3
Chlorotoxin
3
Carboplatin
3
Thiotepa
2
Etoposide
2
Cyclophosphamide
2
Chemotherapy, Adjuvant
2
Amplified Fragment Length Polymorphism Analysis
2
lonafarnib
1
interleukin-4-Pseudomonas exotoxin
1
Verteporfin
1
Valproic Acid
1
Tranexamic Acid
1
Tf-CRM107
1
Tamoxifen
1
Procarbazine
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Pemetrexed
1
Neoadjuvant Therapy
1
Metformin
1
Metabolism
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Astrocytoma
×
Eflornithine
×
Clear all
NCT02796261
2022-01-21
STELLAR
Orbus Therapeutics, Inc.
Phase 3
Unknown
343 enrolled